ARTICLE | Company News
Adventrx, SD Pharma deal
October 10, 2005 7:00 AM UTC
ANX acquired from SD exclusive U.S. rights to ANX-530, an emulsion formulation of vinorelbine in preclinical development for cancer. Financial terms were not disclosed. ANX said the compound's formul...